Q2 2014 13F Holders as of 30 Jun 2014
-
Type / Class
-
Equity / S&P BIOTECH
-
Number of holders
-
121
-
Total 13F shares, excl. options
-
10,369,766
-
Shares change
-
-1,002,054
-
Total reported value, excl. options
-
$1,596,613,069
-
Value change
-
-$148,177,705
-
Put/Call ratio
-
450%
-
Number of buys
-
45
-
Number of sells
-
-84
-
Price
-
$153.99
Significant Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q2 2014
171 filings reported holding XBI - SPDR SERIES TRUST - S&P BIOTECH as of Q2 2014.
SPDR SERIES TRUST - S&P BIOTECH (XBI) has 121 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 10,369,766 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (2,723,980 shares), JPMORGAN CHASE & CO (2,150,000 shares), MORGAN STANLEY (1,431,424 shares), CITIGROUP INC (558,580 shares), UBS AG (455,172 shares), WELLS FARGO & COMPANY/MN (375,752 shares), BANK OF AMERICA CORP /DE/ (337,949 shares), BARCLAYS PLC (268,425 shares), CREDIT SUISSE AG/ (266,215 shares), and STATE OF WISCONSIN INVESTMENT BOARD (230,000 shares).
This table shows the top 121 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.